Document Detail


Cryoablation of accessory pathways in the coronary sinus in young patients: a multicenter study from the Pediatric and Congenital Electrophysiology Society's Working Group on Cryoablation.
MedLine Citation:
PMID:  17472717     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
INTRODUCTION: This is a multicenter retrospective study evaluating the immediate- and mid-term outcomes of cryoablation of accessory pathways in the coronary sinus in children or in patients with congenital heart disease. METHODS AND RESULTS: Twenty-one patients (median age 13.0 years, range 2-40) from six institutions were included. The accessory pathways were concealed in 11 and manifest in 10. Of 12 patients who had coronary sinus angiography, two had large coronary sinus diverticula, one had a dilated coronary sinus due to a left superior vena cava to coronary sinus, and one had a "pouch" at the mouth of the coronary sinus. Six patients underwent ablation procedures with cryoablation alone, while in the remaining 15 patients, both cryoablation and radiofrequency ablation were utilized. The ablation procedure included left-sided endocardial mapping via a retrograde or transseptal approach in 13 (62%). Procedural success was achieved with cryoablation in the coronary sinus in 15/21 (71%). Four patients (19%) had successful radiofrequency ablation at the right or left posterior septum. Two patients (10%) had unsuccessful procedures. Of the 15 patients with initially successful cryoablation procedures, six (40%) had arrhythmia recurrences at a median of 17 days (range 1-120). Recurrences could not be explained by differences in patient or procedural variables. CONCLUSION: Cryoablation in the coronary venous system in young patients is feasible but associated with a high arrhythmia recurrence rate. Cryoablation techniques and/or equipment need to be improved in order to safely create more permanent lesions in this arrhythmia substrate.
Authors:
Kathryn K Collins; Edward K Rhee; Joel A Kirsh; Bryan C Cannon; Frank A Fish; Anne M Dubin; George F Van Hare;
Related Documents :
9558687 - Thoracoscopic radiofrequency ablation of the myocardium.
8737107 - Catheter ablation of incessant ventricular tachycardia: acute and long-term results.
1462907 - Reversibility of left ventricular dysfunction after successful catheter ablation of sup...
7831467 - Catheter ablation for the treatment of atrial tachycardia.
19684037 - Autopsy and clinical context in deceased patients with implanted pacemakers and defibri...
16533187 - Morphologic findings of the ischemic myocardium.
Publication Detail:
Type:  Journal Article; Multicenter Study     Date:  2007-04-30
Journal Detail:
Title:  Journal of cardiovascular electrophysiology     Volume:  18     ISSN:  1540-8167     ISO Abbreviation:  J. Cardiovasc. Electrophysiol.     Publication Date:  2007 Jun 
Date Detail:
Created Date:  2007-05-24     Completed Date:  2007-08-22     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9010756     Medline TA:  J Cardiovasc Electrophysiol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  592-7     Citation Subset:  IM    
Affiliation:
Department of Pediatrics, Division of Cardiology, University of California, San Francisco, California 94143-0632, USA. kathryn.collins@ucsf.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Child
Child, Preschool
Coronary Vessel Anomalies / complications,  diagnosis,  surgery*
Cryosurgery / methods*
Electrophysiologic Techniques, Cardiac / methods
Follow-Up Studies
Heart Conduction System / surgery*
Humans
Retrospective Studies
Tachycardia / diagnosis,  etiology
Treatment Outcome
Comments/Corrections
Comment In:
J Cardiovasc Electrophysiol. 2007 Jun;18(6):598-600   [PMID:  17472711 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Understanding and interpreting dominant frequency analysis of AF electrograms.
Next Document:  CD40-mediated enhancement of immune responses against three forms of influenza vaccine.